Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by jfm1330on Sep 08, 2023 7:33pm
107 Views
Post# 35627130

RE:RE:RE:RE:RE:RE:RE:RE:RE:Well?

RE:RE:RE:RE:RE:RE:RE:RE:RE:Well?Thanks. So we share one active drug because in my case capecitabine is a prodrug of 5-FU (5-fluorouracil). The prodrug allows to take it orally, contrary to 5-FU that needs to be taken by IV because of its poor solubility in water, like docetaxel. But after it's in the body, two enzymatic cleavages of capecitabine allows to transform it into 5-FU in the cancer cells. Also you are right, Avastin is not a drug usually used to treat neuroendocrine cancers.

PWIB123 wrote: jfm1330 - Here's a copy of dad's current regiment.  I don't have access to what he was prescribed the first time, but my understanding is that it included Avastin and two supplemental non-chemo drugs that had names too long for me to write down.  What I remember about the two non-chemo drugs is that the Dr. said they've now learned that they have some nasty side effects and don't feel any real benefit to the cancer itself.  So, they are not including those this time.  My dad nearly experienced kidney failure last year due to Avastin and was going to have to go on dialysis, so he's needing to avoid anything that's too harsh on the kidneys.  Good news is that when he came off of Avastin, his kidneys nearly completely recovered.

Regimen Name: FOLFOX(5-Fluorouracil, Oxaliplatin)

Chemotherapy:
1. Oxaliplatin 85 mg IV over 2 hours on day 1
2. Leucovorin and bolus fluorouracil: OMIT for tolerability
3. 5-Fluorouracil 2400 mg IV continuous infusion over 46 hours starting on day 1

Frequency: Each cycle = 14 days



<< Previous
Bullboard Posts
Next >>